bpc 157 and head injury The effect of pentadecapeptide on hippocampal ischemia/reperfusion injuries in rats BPC-157 for athletes and injury

H., Petrovic A., et al

Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days

FDA approval is a drug-application process

This peptide may improve your bodys natural recovery abilities by balancing these receptors, speeding up how quickly you bounce back from injury

For those without a B12 deficiency, shots are unlikely to provide additional health benefits

It is not a medical service and is not appropriate for anyone with a diagnosed vitamin C deficiency, who should be under their GPs care